International Society for Stem Cell Research 2018 Annual Meeting

When will stem cells restore vision, treat diabetes or replace damaged skin?

2,500+ stem cell scientists under one roof will be discussing: How will CRISPR gene editing change medicine? Can stem cells heal broken hearts? What can we learn about regeneration from axolotls and zebrafish? What’s the economic potential of gene and cell therapies? How do we safely trial and commercialise stem cell medicines?

The International Society for Stem Cell Research 2018 Annual Meeting, bringing global stem cell science to Australia, will be held from 20 to 23 June 2018 at the Melbourne Convention and Exhibition Centre. It will cover topics including cancer stem cells, stem cells as a tool for studying diseases, organoid ‘mini organ’ research, gene therapy and CRISPR gene editing, and progressing gene and cell therapies to the clinic.

Below are the media releases, media alerts and other news items related to the Meeting.

News and interesting content from the Meeting will be tweeted from @ISSCR and using #ISSCR2018.

Media contacts:

Visit the conference websiteRegister for a media pass.

About the International Society for Stem Cell Research (

The International Society for Stem Cell Research is an independent, nonprofit membership organisation established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.

Background: Stem Cell Facts – download an introduction to stem cells and stem cell research (pdf). Stem cell glossary.

Stem cells: making blood, replacing skin, restoring eyesight. Regulations need to protect patients from snake oil merchants

Media preview


  • Stem cells are saving lives today—through bone marrow and cord blood transplants
  • We’ll hear about trials making new skin, restoring sight, treating diabetes, repairing the brain
  • But we’ll also hear of the dangers of risky treatments, snake oil merchants, and new US regulations

Australia is tightening regulations in an effort to reign in rogue stem cell clinics.

The US is also cracking down on clinics marketing unproven treatments to patients. But ‘right to try’ laws there allow seriously ill patients to try experimental therapies without regulation or oversight. Doctors and scientists are alarmed.

More than 2,500 stem cell scientists from 50 countries are in Melbourne next week for the massive International Society for Stem Cell Research 2018 Annual Meeting. They will hear sound science from 150+ speakers, including: [click to continue…]

ISSCR Opposes Proposal to Restrict Fetal Tissue Research

Media release issued by ISSCR

The ISSCR, the largest professional organization of stem cell researchers from around the world, opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released the following statement:

“There is no scientific or ethical basis for the proposed restriction on fetal tissue research, which would roll back decades of consensus in the U.S., irreparably delaying the development of new medical treatments. Research using fetal tissue has saved millions of lives through the development of vaccines for diseases that once ravaged communities across the world. Polio is now almost eradicated, and rubella, measles, chickenpox, and rabies are all preventable diseases because of fetal tissue research. [click to continue…]

ISSCR Responds to President Trump Signing ‘Right to Try’ Law

Media release issued by ISSCR

The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.

“Instead of helping patients, this law will harm patients by providing a route for snake-oil salesman to evade regulation and sell unproven and scientifically dubious therapies to patients,” said ISSCR President Hans Clevers. “In recent months, several patients have been blinded by clinics administering unproven stem cell interventions for eye disease. The Right to Try bill only emboldens bad actors looking for ways to take advantage of desperate patients,” he said. [click to continue…]

ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine

Media release issued by ISSCR

Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia. More than 3,000 stem cell scientists, bioethicists, clinicians, and industry professionals from over 50 countries will share and discuss the latest discoveries and technologies within the field, and how they are advancing regenerative medicine.

The ISSCR annual meeting is the world’s largest meeting focused on stem cell research, with lectures, workshops, poster presentations, and a dynamic exhibition floor with nearly 100 exhibitors. Presentations span the breadth of the field, including topics such as cell-based disease modeling, gene editing and gene therapy, neural, cardiac, blood and other developmental systems and their diseases, and potential breakthrough therapies currently being tested in clinical trials, among others. [click to continue…]

ISSCR Announces Recipients of 2018 Awards

Media release issued by ISSCR

The ISSCR today announces the recipients of its 2018 awards, to be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia.

  • ISSCR Award for Innovation: Michele De Luca, MD, and Graziella Pellegrini, PhD, Full Professors at the University of Modena e Reggio Emilia, Center for Regenerative Medicine, University of Modena e Reggio Emilia, Modena, Italy;
  • ISSCR Dr. Susan Lim Award for Outstanding Young Investigator: Shuibing Chen, PhD, Associate Professor of Chemical Biology in Surgery and in Biochemistry, Weill Cornell Medicine, New York, NY, U.S.;
  • ISSCR Tobias Award Lecture: Connie Eaves, PhD, FRS (Canada), Distinguished Scientist, Terry Fox Laboratory, BC Cancer, and Professor of Medical Genetics, University of British Columbia, Vancouver, BC, Canada;
  • Public Service Award: Megan Munsie, PhD, Associate Professor and Deputy Director, Centre for Stem Cell Systems, The University of Melbourne, and Head of Education, Ethics, Law & Community Awareness Unit, Stem Cells Australia, The University of Melbourne, Australia.

[click to continue…]